Thyroid C-mobile Tumors: In rodent studies, semaglutide has been proven to lead to thyroid C-mobile tumors. It can be unfamiliar whether or not this chance relates to humans, but semaglutide is contraindicated in patients with a private or relatives heritage of medullary thyroid carcinoma (MTC) or patients with Several Endocrine Neoplasia syndrome